John Carnevale is President of Carnevale Associates, LLC, a public policy firm that conducts strategic planning, performance measurement and management, research and data analysis and program and policy evaluation for a range of clients in the public and private sectors.
John Carnevale has more than 30 years’ experience in drug policy, criminal justice and health care policy and program evaluation with the U.S. government and the private sector. He served for more than 11 years at the White House Office of National Drug Control Policy (ONDCP) where he directed formulation of the National Drug Control Strategy and the federal drug control budget to implement it. He was responsible for development of the performance measurement effectiveness system that ONDCP uses to assess the progress of the strategy for achieving its goals and objectives. Dr. Carnevale also conducted research at the Office of Management and Budget and has served three administrations and four drug czars. Since forming his firm, Carnevale Associates, LLC, in 2000, Dr. Carnevale has developed and managed an extensive portfolio of projects involving policy research and evaluation, public budgeting, strategic planning, performance measurement, economic impact evaluations and local law enforcement agency reform. He is currently involved in assessing regulatory matters pertaining to the liberalization of marijuana laws in the United States. Dr. Carnevale is also serving a four-year term on the National Institute on Drug Abuse National Drug Advisory Council. He has also worked as a Public Finance Economist in the U.S. Department of the Treasury in the Office of State and Local Affairs. He has provided expert testimony, briefings and policy analyses for members of Congress, state and local government leaders, international organizations and public interest groups. Dr. Carnevale holds a bachelor’s degree in economics from the University of Maine and a doctorate in public finance economics from the Maxwell School at Syracuse University.